Thats because he wasnt taking any insulin
Data Integrity : Key Lessons from the 2025 FDA Warning Letters Data Integrity Is a Leadership Problem, Not a Regional One: Lessons from 2025 FDA Warning Letters Executive Summary This report provides an evaluation of US FDA Warning Letters issued in calendar year 2025 that cite 21 CFR 211.68(b), focusing on automated and computerized systems used to generate, process, store, and report CGMP data
Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial
Prevents Contamination Bacteria find it hard to grow in the solution due to the presence of benzyl alcohol
The effect in these early weeks is often described as a noticeable reduction in the intensity of hunger signals rather than complete appetite suppression
high confidence), and proved the most effective GLP-1RA drug for glycaemic control